KBC Group
KURA icon

KBC Group’s Kura Oncology KURA Stock Holding History

KBC Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,550
Closed -$48K – 1313
2021
Q3 		$48K Sell
2,550
-2,550
-50% -$48K ﹤0.01% 1240
2021
Q2 		$106K Hold
5,100
– – ﹤0.01% 1223
2021
Q1 		$144K Hold
5,100
– – ﹤0.01% 1217
2020
Q4 		$916K Hold
5,100
– – ﹤0.01% 1159
2020
Q3 		$156K Sell
5,100
-4,600
-47% -$102K ﹤0.01% 1147
2020
Q2 		$158K Buy
9,700
+4,850
+100% +$70K ﹤0.01% 1179
2020
Q1 		$48K Hold
4,850
– – ﹤0.01% 1202
2019
Q4 		$67K Buy
4,850
+2,475
+104% +$36.7K ﹤0.01% 1396
2019
Q3 		$36K Buy
2,375
+525
+28% +$9.35K ﹤0.01% 1402
2019
Q2 		$36K Hold
1,850
– – ﹤0.01% 1379
2019
Q1 		$31K Buy
+1,850
New +$28.5K ﹤0.01% 1351

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

KBC Group's KURA Position: Q4 2021 in Review

KBC Group sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 2,550 shares — an estimated $48K sold.

KBC Group first reported a position in KURA in Q1 2019 and held it in 11 quarters. The position peaked at $916K in Q4 2020. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • KBC Group reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
  • KBC Group sold 2,550 Kura Oncology shares in Q4 2021, an estimated $48K.
  • KBC Group first reported a position in Kura Oncology in Q1 2019 and held it in 11 quarters.
  • KBC Group's Kura Oncology position peaked at $916K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on KBC Group's 13F filing for Q4 2021, filed 3 Feb 2022.